Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

technospeak.fr Blueprint · Rev.39

Sheet A · Product board

5-amino-1mq nnmt inhibitor peptide or small molecule Online Pack Size:3 Vials research peptide product AOD-9604 Peptide for Targeted

Unit price

USD26.95

USD59.95

Pay in 4 interest-free payments of $6.74 Learn more

Field rating

4.6

Verified studio score · Spec revision current

Fit · Size

5-amino-1mq nnmt inhibitor peptide or small molecule

5-amino-1mq nnmt inhibitor peptide or small molecule Online Pack Size:3 Vials research peptide product AOD-9604 Peptide for Targeted

SKU: 71631016447

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 31 - Nov 5

Description

5-amino-1mq nnmt inhibitor peptide or small molecule Online Pack Size:3 Vials research peptide product AOD-9604 Peptide for Targeted

AOD-9604 Peptide for Targeted Fat Loss | Valeo Health

V., Burchard J., Mao M., et al

research peptide product

Pack Size:3 Vials

(PubMed PMID: 24717514) Wilding JPH, et al

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

Survodutide Peptide Dosing Guide: GLP-1/Glucagon Protocol & Safety (2026)

Survodutide Peptide Dosing Guide: GLP-1/Glucagon Protocol & Safety (2026)

US$ 25.09

4.7 (18 reviews)

Retatrutide vs CagriSema vs Survodutide: Three Next-Gen Weight Loss Drugs Compared

Retatrutide vs CagriSema vs Survodutide: Three Next-Gen Weight Loss Drugs Compared

US$ 27.49

4.8 (10 reviews)

Blog

Blog

US$ 26.92

4.0 (29 reviews)

Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination

Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination

US$ 27.73

4.2 (30 reviews)

Survodutide Peptide: Mechanism, Research Benefits, and Comparisons

Survodutide Peptide: Mechanism, Research Benefits, and Comparisons

US$ 23.39

5.0 (11 reviews)

Cagrilintide Dosage: Doctor Explains Dosing for Patients to Follow

Cagrilintide Dosage: Doctor Explains Dosing for Patients to Follow

US$ 22.15

4.2 (16 reviews)

Cagrilintide (AM833) vs Survodutide (BI 456906) - Research Comparison

Cagrilintide (AM833) vs Survodutide (BI 456906) - Research Comparison

US$ 21.42

4.7 (21 reviews)

Survodutide vs tirzepatide: how the next-generation dual agonists actually compare

Survodutide vs tirzepatide: how the next-generation dual agonists actually compare

US$ 21.72

4.8 (25 reviews)

Cagrilintide vs retatrutide: amylin analogue vs triple agonist compared

Cagrilintide vs retatrutide: amylin analogue vs triple agonist compared

US$ 28.28

4.1 (16 reviews)

survodutide vs cagrilintide Tirzepatide

survodutide vs cagrilintide Tirzepatide

US$ 22.83

4.0 (21 reviews)

survodutide vs cagrilintide Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of

survodutide vs cagrilintide Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of

US$ 28.49

4.9 (26 reviews)

bpc-157 human clinical trials evidence safety regulatory status bpc 157 fda Repost @peptides with @use

bpc-157 human clinical trials evidence safety regulatory status bpc 157 fda Repost @peptides with @use

US$ 21.42

4.6 (26 reviews)

FDA's Review Of Peptides Signals A Growing Public Health Challenge

FDA's Review Of Peptides Signals A Growing Public Health Challenge

US$ 23.08

5.0 (28 reviews)

bpc-157 human clinical trials evidence safety regulatory status trial fda warning approval unapproved new drug

bpc-157 human clinical trials evidence safety regulatory status trial fda warning approval unapproved new drug

US$ 25.68

4.4 (5 reviews)

fda warning peptides bpc-157 safety unapproved Understanding the Legal Risks of and Other – Holt Law bpc-157 human clinical trials status –

fda warning peptides bpc-157 safety unapproved Understanding the Legal Risks of and Other – Holt Law bpc-157 human clinical trials status –

US$ 26.77

4.2 (29 reviews)

fda warning bpc-157 unapproved new drug human clinical trials status bpc 157 evidence safety Comment

fda warning bpc-157 unapproved new drug human clinical trials status bpc 157 evidence safety Comment

US$ 24.18

4.5 (13 reviews)

FDA panel votes to place popular peptide BPC-157 on compounding list

FDA panel votes to place popular peptide BPC-157 on compounding list

US$ 28.95

4.7 (30 reviews)

bpc-157 human clinical evidence safety regulatory status bpc 157 An FDA Committee Just Voted in

bpc-157 human clinical evidence safety regulatory status bpc 157 An FDA Committee Just Voted in

US$ 24.00

4.0 (16 reviews)

bpc-157 human evidence safety review clinical trials fda warning regulatory status What Is BPC-157? How It FDA panel narrowly backs unapproved – Multifunctionality and Possible Medical Application –

bpc-157 human evidence safety review clinical trials fda warning regulatory status What Is BPC-157? How It FDA panel narrowly backs unapproved – Multifunctionality and Possible Medical Application –

US$ 28.98

4.8 (11 reviews)

BPC-157 is an investigational peptide that continues to receive attention in wellness and medical research. However, it is not currently FDA-approved, and reliable human safety and effectiveness data

BPC-157 is an investigational peptide that continues to receive attention in wellness and medical research. However, it is not currently FDA-approved, and reliable human safety and effectiveness data

US$ 27.36

4.5 (21 reviews)